Sedative and Analgesic Pharmacokinetics During Pediatric ECMO
Overview
Affiliations
Sedatives and analgesics are often administered to critically ill children supported by extracorporeal membrane oxygenation (ECMO) to facilitate comfort and to decrease risks of life-threatening complications. Optimization of sedative and analgesic dosing is necessary to achieve desired therapeutic benefits and must consider interactions between the circuit and patient that may affect drug metabolism, clearance, and impact on target organs. This paper reviews existing and pediatric literature concerning the effects of the ECMO circuit on sedative and analgesic disposition and offers dosing guidance for the management of critically ill children receiving these drugs.
Pharmacokinetic Research in Pediatric Extracorporeal Therapies: Current State and Future Directions.
Stitt G, Thibault C, Mueller B, Cies J, Daniel J, Arikan A Blood Purif. 2024; 53(6):520-526.
PMID: 39363977 PMC: 11449264. DOI: 10.1159/000534828.
Extraction of ketamine and dexmedetomidine by extracorporeal life support circuits★.
Chevalier A, Hunt J, Whelan A, McKnite A, Watt K, Green D J Extra Corpor Technol. 2024; 56(3):101-107.
PMID: 39303131 PMC: 11415041. DOI: 10.1051/ject/2024016.
Smits A, Annaert P, Cavallaro G, De Cock P, de Wildt S, Kindblom J Br J Clin Pharmacol. 2021; 88(12):4965-4984.
PMID: 34180088 PMC: 9787161. DOI: 10.1111/bcp.14958.